Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening

Abstract

These experiments provide a proof-of-principle that virtual screening can be used to identify specific inhibitors of EBNA1 that may have potential for treatment of EBV latent infection.